NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSE

Objective: Hepatitis C (HC) is an infectious disease of the liver and is associated with multiple complications. It has been reported that the medicines, which are being used to treat HC, cause neuropsychiatric adverse effects like depression, sleep disturbances, insomnia and irritability. Moreover,...

Full description

Bibliographic Details
Main Authors: Sadia Qureshi, MH Qazi, Muhammad Tahir Aziz
Format: Article
Language:English
Published: University of Faisalabad 2017-06-01
Series:Journal of University Medical & Dental College
Subjects:
Online Access:http://jumdc.com/index.php/jumdc/article/view/135
_version_ 1811284645860343808
author Sadia Qureshi
MH Qazi
Muhammad Tahir Aziz
author_facet Sadia Qureshi
MH Qazi
Muhammad Tahir Aziz
author_sort Sadia Qureshi
collection DOAJ
description Objective: Hepatitis C (HC) is an infectious disease of the liver and is associated with multiple complications. It has been reported that the medicines, which are being used to treat HC, cause neuropsychiatric adverse effects like depression, sleep disturbances, insomnia and irritability. Moreover, hepatitis C virus (HCV) infection itself is also strongly associated to psychiatric disorders. This study was conducted to check the impact of these neuropsychiatric adverse effects on treatment outcome. Method: A prospective study was designed to look for the neuropsychiatric adverse effects in HCV genotype 3a infected patients, as HCV 3a is on the top to causeHCV infection in South East Asian population, when treated with Interferon alpha and ribavirin (INF + RV) or pegylated interferon alpha and ribavirin (Peg INF + RV) and their effects on treatment outcome. Results: This study was conducted in two different public hospitals of Lahore. It was found that these patients had depression, anxiety, emotional lability, irritability and insomnia. It was also observed that the patients who were treated with INF + RV had higher frequency of neuropsychiatric adverse effects. Moreover, when we compared the occurrence of these adverse effects with other populations our study group had much lower frequency. Conclusion: It was concluded that a multidisciplinary tam approach with timely strategies could improve the treatment outcome of HC patients.
first_indexed 2024-04-13T02:32:43Z
format Article
id doaj.art-128ef2e853e046f69cba12e2d2ece3a3
institution Directory Open Access Journal
issn 2221-7827
2310-5542
language English
last_indexed 2024-04-13T02:32:43Z
publishDate 2017-06-01
publisher University of Faisalabad
record_format Article
series Journal of University Medical & Dental College
spelling doaj.art-128ef2e853e046f69cba12e2d2ece3a32022-12-22T03:06:30ZengUniversity of FaisalabadJournal of University Medical & Dental College2221-78272310-55422017-06-0183NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSESadia Qureshi0MH Qazi1 Muhammad Tahir Aziz2Institute of molecular biology and biotechnology, The University of Lahore. *Director Institute of molecular biology and biotechnology, The University of Lahore, PakistanDepartment of Pharmacy, Quaid-i-Azam University, IslamabadObjective: Hepatitis C (HC) is an infectious disease of the liver and is associated with multiple complications. It has been reported that the medicines, which are being used to treat HC, cause neuropsychiatric adverse effects like depression, sleep disturbances, insomnia and irritability. Moreover, hepatitis C virus (HCV) infection itself is also strongly associated to psychiatric disorders. This study was conducted to check the impact of these neuropsychiatric adverse effects on treatment outcome. Method: A prospective study was designed to look for the neuropsychiatric adverse effects in HCV genotype 3a infected patients, as HCV 3a is on the top to causeHCV infection in South East Asian population, when treated with Interferon alpha and ribavirin (INF + RV) or pegylated interferon alpha and ribavirin (Peg INF + RV) and their effects on treatment outcome. Results: This study was conducted in two different public hospitals of Lahore. It was found that these patients had depression, anxiety, emotional lability, irritability and insomnia. It was also observed that the patients who were treated with INF + RV had higher frequency of neuropsychiatric adverse effects. Moreover, when we compared the occurrence of these adverse effects with other populations our study group had much lower frequency. Conclusion: It was concluded that a multidisciplinary tam approach with timely strategies could improve the treatment outcome of HC patients.http://jumdc.com/index.php/jumdc/article/view/135hepatitis CHepatitis C virusneuropsychiatric adverse effectstreatment outcome
spellingShingle Sadia Qureshi
MH Qazi
Muhammad Tahir Aziz
NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSE
Journal of University Medical & Dental College
hepatitis C
Hepatitis C virus
neuropsychiatric adverse effects
treatment outcome
title NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSE
title_full NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSE
title_fullStr NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSE
title_full_unstemmed NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSE
title_short NEUROPSYCHIATRIC ADVERSE EFFECTS OF HVC TREATMENT AND THEIR IMPACT ON THE TREATMENT RESPONSE
title_sort neuropsychiatric adverse effects of hvc treatment and their impact on the treatment response
topic hepatitis C
Hepatitis C virus
neuropsychiatric adverse effects
treatment outcome
url http://jumdc.com/index.php/jumdc/article/view/135
work_keys_str_mv AT sadiaqureshi neuropsychiatricadverseeffectsofhvctreatmentandtheirimpactonthetreatmentresponse
AT mhqazi neuropsychiatricadverseeffectsofhvctreatmentandtheirimpactonthetreatmentresponse
AT muhammadtahiraziz neuropsychiatricadverseeffectsofhvctreatmentandtheirimpactonthetreatmentresponse